Open AccessLet-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia
Author(s) -
Emmanouil Rizos,
Nikolaos Siafakas,
Eleni Katsantoni,
Eleni Skourti,
V. Salpeas,
Ioannis Rizos,
James N. Tsoporis,
Anastasia N. Kastania,
Anastasia Filippopoulou,
Nikolaos I. Xiros,
Demetrios Margaritis,
Thomas G. Parker,
Charalabos Papageorgiou,
Vassilios Zoumpourlis
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0123522
Subject(s) - microrna , schizophrenia (object oriented programming) , context (archaeology) , cancer , gene expression , gene , case control study , medicine , bioinformatics , biology , oncology , psychiatry , genetics , paleontology
Recent evidence supports a role of microRNAs in cancer and psychiatric disorders such as schizophrenia and bipolar disorder, through their regulatory role on the expression of multiple genes. The rather rare co-morbidity of cancer and schizophrenia is an old hypothesis which needs further research on microRNAs as molecules that might exert their oncosuppressive or oncogenic activity in the context of their role in psychiatric disorders. The expression pattern of a variety of different microRNAs was investigated in patients (N = 6) suffering from schizophrenia termed control, patients with a solid tumor (N = 10) and patients with both schizophrenia and tumor (N = 8). miRNA profiling was performed on whole blood samples using the miRCURY LNA microRNA Array technology (6th & 7th generation). A subset of 3 microRNAs showed a statistically significant differential expression between the control and the study groups. Specifically, significant down-regulation of the let-7p-5p, miR-98-5p and of miR-183-5p in the study groups (tumor alone and tumorand schizophrenia) was observed (p<0.05). The results of the present study showed that let-7, miR-98 and miR-183 may play an important oncosuppressive role through their regulatory impact in gene expression irrespective of the presence of schizophrenia, although a larger sample size is required to validate these results. Nevertheless, further studies are warranted in order to highlight a possible role of these and other micro-RNAs in the molecular pathways of schizophrenia.